Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.68 |
| ▸ | FOS | P01100 | 1/20 | 0.68 |
| ▸ | JUN | P05412 | 1/20 | 0.68 |
| ▸ | BCHE | P06276 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.62 |
| ▸ | MAOA | P21397 | 2/20 | 0.62 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.61 |
| ▸ | RELA | Q04206 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2632249 | 1.00 | MAOB (0.68) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL29374516 | 1.00 | MAOB (0.68) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL23273962 | 0.89 | MAOB (0.63) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL23273963 | 0.89 | MAOB (0.63) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL15932965 | 0.89 | MAOB (0.58) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL3580362 | 0.88 | FOS (0.79) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL3580365 | 0.88 | FOS (0.79) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL29822711 | 0.88 | FOS (0.79) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL80787 | 0.86 | FOS (0.72) | MAOBFOSJUNBCHECYP1A2 | |
| SCHEMBL30584119 | 0.86 | FOS (0.72) | MAOBFOSJUNBCHECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118255708-A | Polysubstituted carbazole derivative and synthesis method thereof | 重庆理工大学 | 2024-06-28 | — | — | CN | claimed |
| CN-1882602-A | Modulation and degradation of hyaluronan synthesis in the treatment of disease | MEDITECH RES LTD (AU) | 2006-12-20 | — | — | CN | claimed |
| CN-1681470-A | Agent for dyeing keratinous fibres | HENKEL KGAA (DE) | 2005-10-12 | — | — | CN | claimed |
| EP-4727923-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | University of Georgia Research Foundation, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIV GEORGIA (US) | 2026-04-09 | — | — | US | disclosed |
| EP-3930849-B1 | THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS | KEZAR LIFE SCIENCES (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2024258904-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| CN-118255708-A | Polysubstituted carbazole derivative and synthesis method thereof | 重庆理工大学 | 2024-06-28 | — | — | CN | disclosed |
| CN-113304129-B | Application of mono-ketene monocarbonyl curcumin analogue in preparing antioxidant drugs | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 2022-11-08 | — | — | CN | disclosed |
| US-20220289657-A1 | COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) | 2022-09-15 | — | — | US | disclosed |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
| EP-0146271-A2 | Aralykyl (arylethynyl) aralkyl amines for use as vasodilators and antihypertensives | McNeilab, Inc. (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0145361-A2 | Acetylene derivatives for the treatment of hypertension and angina | McNeilab, Inc. (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4293391-A | Cadmium plating baths and methods for electrodepositing bright cadmium deposits | ROHCO, INC. (US) | 1981-10-06 | — | — | US | disclosed |
| US-4270989-A | AN AQUEOUS SOLUTION OF A IONIZABLE CADMIUM COMPOUND, A FREE ACID, AND AN ALKYLENE OXIDE ADDUCT OR A POLYOXYALKYLENE GLYCOL HAVING A PHOSPHATE, CARBOXYLATE, OR ARYL SULFATE GROUP | ROHCO, INC. (US) | 1981-06-02 | — | — | US | disclosed |
| US-4229268-A | SULFUR-CONTAINING POLYOXYALKYLENE GLYCOL IN BATHS | ROHCO, INC. (US) | 1980-10-21 | — | — | US | disclosed |
| US-4162947-A | AROMATIC SULFONIC ACID OR SALT, ZINC AND AMMONIUM COMPOUNDS | R. O. HULL & COMPANY, INC. (US) | 1979-07-31 | — | — | US | disclosed |
| US-4146441-A | Additive compositions, baths, and methods for electrodepositing bright zinc deposits | R. O. HULL & COMPANY, INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4146442-A | Zinc electroplating baths and process | R. O. HULL & COMPANY, INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4075066-A | Electroplating zinc, ammonia-free acid zinc plating bath therefor and additive composition therefor | R. O. HULL & COMPANY, INC. (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | CD47, SLC11A2, G6PD | MAOB 4337/4885FOS 4508/4885JUN 4850/4885 |
| US-20220289657-A1 | COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | HSD11B1, GRHPR, TIPRL | MAOB 4774/4885FOS 2502/4885JUN 2500/4885 |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | MAOB 3887/4885FOS 3374/4885JUN 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.